These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 307012)

  • 21. Regulation of IgE antibody synthesis.
    Konig W; Pfeiffer P; Theobald K; Szperalski B; Voshaar T; Hess KH; Bohn A
    Allergol Immunopathol (Madr); 1983; 11(4):277-84. PubMed ID: 6228129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-idiotypic antibodies in the treatment of allergies.
    Hébert J; Boutin Y
    Adv Exp Med Biol; 1996; 409():431-7. PubMed ID: 9095278
    [No Abstract]   [Full Text] [Related]  

  • 23. Prospects for the clinical control of IgE synthesis.
    Katz DH
    Prog Clin Immunol; 1980; 4():127-50. PubMed ID: 6992217
    [No Abstract]   [Full Text] [Related]  

  • 24. Reaginic antibody formation in the mouse. X. Possible role of suppressor T cells in transient IgE antibody responses.
    Tamura SI; Ishizaka K
    J Immunol; 1978 Mar; 120(3):837-43. PubMed ID: 305447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic Potential of Monoclonal IgA Antibodies in Allergic Diseases: Suppressive Effect of IgA on Immune Responses Induced By Re-exposure to Antigen in Sensitized Mice by Monoclonal IgE Antibody That Binds to a Different Epitope of the Same Antigen.
    Yamaki K; Yoshino S
    Monoclon Antib Immunodiagn Immunother; 2015 Apr; 34(2):83-9. PubMed ID: 25897605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological tolerance to allergenic protein determinants: a therapeutic approach for selective inhibition of IgE antibody production.
    Liu FT; Katz DH
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1430-4. PubMed ID: 286326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of Hymenoptera venoms for immunotherapy on the basis of patient's IgE antibody cross-reactivity.
    Hamilton RG; Wisenauer JA; Golden DB; Valentine MD; Adkinson NF
    J Allergy Clin Immunol; 1993 Nov; 92(5):651-9. PubMed ID: 8227855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergen IgE-isotype-specific suppression by maternally derived monoclonal anti-IgG-idiotype.
    Tanasa RI; Trad A; Lange H; Grötzinger J; Lemke H
    Allergy; 2010 Jan; 65(1):16-23. PubMed ID: 19624555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgE isotype suppression in anti-epsilon-treated mice.
    Bozelka BE; McCants ML; Salvaggio JE; Lehrer SB
    Immunology; 1982 Jul; 46(3):527-32. PubMed ID: 6807838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profound reduction in allergen sensitivity following treatment with a novel allergy vaccine.
    Hellman L
    Eur J Immunol; 1994 Feb; 24(2):415-20. PubMed ID: 8299691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The allergy adjuvant effect of particles - genetic factors influence antibody and cytokine responses.
    Nygaard UC; Aase A; Løvik M
    BMC Immunol; 2005 Jun; 6():11. PubMed ID: 15967044
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Half-life of IgE in serum and skin: Consequences for anti-IgE therapy in patients with allergic disease.
    Lawrence MG; Woodfolk JA; Schuyler AJ; Stillman LC; Chapman MD; Platts-Mills TA
    J Allergy Clin Immunol; 2017 Feb; 139(2):422-428.e4. PubMed ID: 27496596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hyposensitization therapy: current status].
    Fiandor Román AM; Pascual Marcos C
    An Esp Pediatr; 1985 Apr; 22(5):345-8. PubMed ID: 2409854
    [No Abstract]   [Full Text] [Related]  

  • 34. Hapten-specific IgE antibody responses in mice. IX. Suppression of IgE antibody production by passive transfer of T cells from adjuvant-primed syngeneic mice.
    Chiorazzi N; Tung AS; Katz DH
    J Immunol; 1979 Apr; 122(4):1495-501. PubMed ID: 312844
    [No Abstract]   [Full Text] [Related]  

  • 35. Monovalent fusion proteins of IgE mimotopes are safe for therapy of type I allergy.
    Ganglberger E; Barbara Sponer ; Schöll I; Wiedermann U; Baumann S; Hafner C; Breiteneder H; Suter M; Boltz-Nitulescu G; Scheiner O; Jensen-Jarolim E
    FASEB J; 2001 Nov; 15(13):2524-6. PubMed ID: 11641259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of IgE antibody production in SJL mice. I. Nonspecific suppressor T cells.
    Watanabe N; Kojima S; Ovary Z
    J Exp Med; 1976 Apr; 143(4):833-45. PubMed ID: 1082918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing the allergenicity and adjuvanticity of allergens.
    Deifl S; Bohle B
    Immunotherapy; 2011 Jul; 3(7):881-93. PubMed ID: 21751956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Internal images: human anti-idiotypic Fab antibodies mimic the IgE epitopes of grass pollen allergen Phl p 5a.
    Hantusch B; Knittelfelder R; Wallmann J; Krieger S; Szalai K; Untersmayr E; Vogel M; Stadler BM; Scheiner O; Boltz-Nitulescu G; Jensen-Jarolim E
    Mol Immunol; 2006 Jul; 43(14):2180-7. PubMed ID: 16510185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG4 but no IgG1 antibody production after intralymphatic immunotherapy with recombinant MAT-Feld1 in human.
    Freiberger SN; Zehnder M; Gafvelin G; Grönlund H; Kündig TM; Johansen P
    Allergy; 2016 Sep; 71(9):1366-70. PubMed ID: 27253988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New immunologic perspectives on specific desensitization].
    de Weck AL
    Schweiz Med Wochenschr; 1977 Dec; 107(48):1736-41. PubMed ID: 303804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.